Richard Lehman’s journal review – 1 November 2010

JAMA  27 Oct 2010  Vol 304 Perhaps the greatest prize in preventive medicine this century will be the discovery of an effective non-surgical intervention to cure obesity. This study doesn’t quite achieve that, but at least it shows that there is still something to be gained from those two old mainstays, diet and exercise. The […]

Read More…

Richard Lehman’s journal review, 18 October 2010

JAMA 13 Oct 2010 Vol 304 Cardiac surgery was once considered too bloody even to contemplate: now it is commonplace. But there is still no agreement in practice about how much blood should be transfused following heart surgery – rates of transfusion vary between 8% and 93% in similar units across the USA (p.1586). The […]

Read More…

Richard Lehman’s journal review – 11 October 2010

JAMA  6 Oct 2010  Vol 304 1447   “In 2005, because our evaluation of out-of-hospital cardiac arrest in Arizona revealed dismal outcomes, we established a statewide program aimed at improving survival.” I like the way the chief investigator uses the word dismal: I like his name, which is Bentley Bobrow: and I like his study too, […]

Read More…

Richard Lehman’s journal review 29 September 2010

JAMA  22-29 Sep 2010  Vol 304 1331   Heart failure management is supposedly a showcase for evidence-based medicine, with lots of interventional trials to guide the deployment of ACE inhibitors, angiotensin receptor blockers, beta-adrenergic blockers and so on: but in fact it is just a mess. These drugs can certainly improve prognosis in some patients but […]

Read More…

Richard Lehman’s journal review – 20 September 2010

JAMA  15 Sep 2010  Vol 304 1173  Medical students dominate this week’s JAMA. These are American medical students, who all have degrees in something else before they start medicine, so they should be well rounded, relaxed human beings in the prime of youth, enjoying a new and interesting course of study which will result in their […]

Read More…

Richard Lehman’s journal review – 13 September 2010

JAMA 8 Sep 2010 Vol 304 1073 “Adenocarcinoma of the pancreas is arguably the most challenging of human malignancies”, as the commentary on this study of adjuvant chemotherapy points out. And in fact the ESPAC-3 study doesn’t get us any further, except to rule out any benefit from adding gemcitabine to a regimen of fluouracil […]

Read More…

Richard Lehman’s journal review – 6 September 2010

JAMA 1 Sep 2010  Vol 304 967    A couple of weeks ago, the BMJ published a rather strange piece about the terrible psychological effects of chemical castration in men with prostate cancer. But although I’ll no doubt be sorry to part with that aspect of myself if I ever have to, this pales into insignificance […]

Read More…